EXCHANGE AGREEMENTWarrant Exchange Agreement • February 11th, 2013 • Tengion Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 11th, 2013 Company Industry JurisdictionThis Warrant Exchange Agreement (this “Agreement”), effective as of December 31, 2012, is by and between Tengion, Inc., a Delaware corporation (the “Company”), and the investor identified on Schedule A hereto (the “Warrantholder”). Capitalized terms not defined herein shall have the meanings set forth in the Securities Purchase Agreement dated as of March 1, 2011, by and among the Company and the purchasers party thereto (the “Securities Purchase Agreement”).
EXCHANGE AGREEMENTWarrant Exchange Agreement • February 11th, 2013 • Tengion Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 11th, 2013 Company Industry JurisdictionThis Warrant Exchange Agreement (this “Agreement”), effective as of December 31, 2012, is by and between Tengion, Inc., a Delaware corporation (the “Company”), and the investor identified on Schedule A hereto (the “Warrantholder”). Capitalized terms not defined herein shall have the meanings set forth in the Securities Purchase Agreement dated as of March 1, 2011, by and among the Company and the purchasers party thereto (the “Securities Purchase Agreement”).
EXCHANGE AGREEMENTWarrant Exchange Agreement • February 11th, 2013 • Tengion Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 11th, 2013 Company Industry JurisdictionThis Warrant Exchange Agreement (this “Agreement”), effective as of December 31, 2012, is by and between Tengion, Inc., a Delaware corporation (the “Company”), and the investor identified on Schedule A hereto (the “Warrantholder”). Capitalized terms not defined herein shall have the meanings set forth in the Securities Purchase Agreement dated as of March 1, 2011, by and among the Company and the purchasers party thereto (the “Securities Purchase Agreement”).
EXCHANGE AGREEMENTWarrant Exchange Agreement • February 11th, 2013 • Tengion Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 11th, 2013 Company Industry JurisdictionThis Warrant Exchange Agreement (this “Agreement”), effective as of December 31, 2012, is by and between Tengion, Inc., a Delaware corporation (the “Company”), and the investor identified on Schedule A hereto (the “Warrantholder”). Capitalized terms not defined herein shall have the meanings set forth in the Securities Purchase Agreement dated as of March 1, 2011, by and among the Company and the purchasers party thereto (the “Securities Purchase Agreement”).
EXCHANGE AGREEMENTWarrant Exchange Agreement • January 11th, 2013 • Medtronic Inc • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJanuary 11th, 2013 Company Industry JurisdictionThis Warrant Exchange Agreement (this “Agreement”), effective as of December 31, 2012, is by and between Tengion, Inc., a Delaware corporation (the “Company”), and the investor identified on Schedule A hereto (the “Warrantholder”). Capitalized terms not defined herein shall have the meanings set forth in the Securities Purchase Agreement dated as of March 1, 2011, by and among the Company and the purchasers party thereto (the “Securities Purchase Agreement”).